DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $29.50 Average Target Price from Brokerages

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has received a consensus rating of “Hold” from the nine research firms that are currently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $29.50.

A number of research analysts recently commented on the stock. Needham & Company LLC decreased their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Barrington Research lowered their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Evercore ISI decreased their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Finally, StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Tuesday, November 19th.

DENTSPLY SIRONA Stock Up 0.7 %

XRAY stock opened at $18.77 on Thursday. The company has a market cap of $3.73 billion, a price-to-earnings ratio of -9.07, a P/E/G ratio of 1.83 and a beta of 1.02. DENTSPLY SIRONA has a twelve month low of $17.21 and a twelve month high of $37.60. The business has a 50 day moving average price of $23.25 and a two-hundred day moving average price of $25.09. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. During the same quarter in the previous year, the business earned $0.49 earnings per share. The business’s revenue was up .4% compared to the same quarter last year. Analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently made changes to their positions in the company. First Eagle Investment Management LLC boosted its stake in shares of DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after purchasing an additional 3,283,965 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in DENTSPLY SIRONA by 42.0% during the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after acquiring an additional 1,308,411 shares in the last quarter. Cooke & Bieler LP grew its stake in DENTSPLY SIRONA by 16.2% in the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after acquiring an additional 1,046,105 shares during the period. Invenomic Capital Management LP bought a new stake in DENTSPLY SIRONA during the 3rd quarter valued at $23,724,000. Finally, National Bank of Canada FI increased its position in shares of DENTSPLY SIRONA by 684.6% during the second quarter. National Bank of Canada FI now owns 876,400 shares of the medical instruments supplier’s stock worth $21,586,000 after acquiring an additional 764,700 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.